Drawing for MICROMET

USPTO serial 76444543

MICROMET

Reviewed by CopyMark Law Group

Reg. 3014387Status 710
Filing date
Status date
Registration date
Nov 15, 2005
Examiner
CHARLON, BARNEY
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with MICROMET?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

G. Patrick Sage

G PATRICK SAGE HUESCHEN & SAGE PLLC7TH FL KALAMAZOO BLDG107 W MICHIGAN AVEKALAMAZOO, MI 49007

Goods and services

ClassDescriptionStatusFirst use
001Chemical preparations, namely, buffers, polypeptides, nucleic acids for scientific research purposes, water-oil solutions, chemical preparations in the form of powders, chemical preparations in the form of ointments, lyophilisates, dispersion solutions, emulsions, suspensions, liposomes, and chemical additives all for scientific purposes; chemical agents, namely, polypeptides, nucleic acids for characterizing and examination of animal and human diseases, eukaryotic cells, eukaryotic cell culture lines, microorganisms, nucleic acids, polypeptides, animal and human material in the nature of cells out of cell culture, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples, of cells isolated with florescence activated cell sorting FACS devices or with receptor/ligand binding, of cells of chemically fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, all for scientific research purposes; eukaryotic cells, eukaryotic cell culture lines, microorganisms, nucleic acids, polypeptides, animal and human material in the nature of cells out of cell culture, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples, of cells isolated with FACS or with receptor/ligand binding, of cells of chemically fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, all for scientific research purposesSECTION 8 - CANCELLED
005Medicaments, namely, for use in the treatment of tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, infectious diseases,osteoporosis, graft versus host and host versus graft diseases, transplant rejection,coronary heart diseases, and minimal residual diseases, restenosis, metabolic disorders,neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases; pharmaceutical and veterinary preparations, namely, for use in the treatment of tumorous diseases,proliferative diseases, allergies, auto-immune diseases, inflammation, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases; and minimal residual diseases; restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis,immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases; preparations for clinical diagnosis and analysis of animal and human diseases for clinical medical use, eukaryotic cells,eukaryotic cell culture lines, animal and human material in the nature of cells out of cell culture and, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples, of cells isolated with FACS or with receptor/ligand binding, of cells of chemically fixed tissues, of micro metastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells; eukaryotic cells, eukaryotic cell culture lines, microorganisms, nucleic acids, polypeptides, animal and human material in the nature of cells out of cell culture, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples, of cells isolated with FACSor with receptor/ligand binding, of cells of chemically fixed tissue, of micrometasttic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, all for medical purposes, namely, for use in the treatment of tumorous diseases, proliferative diseases, allergies, auto immune diseases,inflammation, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, and minimal residual diseases,restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy,rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases,neurodegenerative diseases; sanitary preparations for medical purposes, namely, agents for dental careSECTION 8 - CANCELLED
009Diagnostic and testing apparatus and systems and instruments in the nature of syringes, needles, biopsy needles, DNA-array devices, RNA-array devices, array readers, scanners, imaging devices, hybridization machines, hybridization chambers, thermocyclers, centrifuges, reaction tubes, centrifuge tubes, filters, rotators, mixers, beads, fluorescence activated cell sorting FACS devices, lasers, balloon instruments and magnetic devices, for scientific research purposes, all for the development of medicaments, identification and analysis of eukaryotic cells, eukaryotic cell culture lines, animal and human material, microorganisms, nucleic acids and polypeptidesSECTION 8 - CANCELLED
010Diagnostic and testing apparatus and systems and instruments in the nature of syringes, needles, biopsy needles, DNA-array devices, RNA-array devices, array readers, scanners, imaging devices, hybridization machines, hybridization chambers, thermocyclers, centrifuges, reaction tubes, centrifuge tubes, filters, rotators, mixers, beads, Flourescence Activated Cell Sorting FACS devices, lasers, balloon instruments and magnetic devices, for clinical medical purposes, all for the clinical diagnosis and analysis for animal and human diseases, eukaryotic cells, eukaryotic cell culture lines and animal and human materialSECTION 8 - CANCELLED
042Scientific research and industrial, medical, pharmaceutical, chemical, biological, biochemical, biotechnological research, in the field of molecular biology, biotechnology, genetics, medicine, pharmacology, cell biology; identification of target structures for the development of medicaments, identification of cell growth and differentiation; determination of the pathogenesis of animal and human diseases; development of medicaments; development of technologies and means for scientific research and industrial, medical, pharmaceutical, chemical, biological, biochemical, biotechnological research, namely, of eukaryotic cells, eukaryotic cell culture lines, animal and human material, nucleic acids and polypeptides; performance of diagnoses and analyses for medical research purposes; eukaryotic cells, eukaryotic cell culture lines, animal and human material, microorganisms, nucleic acids and polypeptidesSECTION 8 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 22, 2012C8..CANCELLED SEC. 8 (6-YR)
Nov 15, 2005R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 6, 2005DMCCDATA MODIFICATION COMPLETED
Oct 2, 2005TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 20, 2005TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 28, 2005DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION
Jun 28, 2005IUCNNOTICE OF ALLOWANCE CANCELLED
May 24, 2005NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 26, 2005ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Feb 18, 2005FAXXFAX RECEIVED
Nov 22, 2004ETOFEXTENSION OF TIME TO OPPOSE RECEIVED
Oct 26, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 6, 2004NPUBNOTICE OF PUBLICATION
Jul 14, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jun 22, 2004CNEAEXAMINERS AMENDMENT MAILED
Jun 19, 2004XAECEXAMINER'S AMENDMENT ENTERED
May 10, 2004CNEAEXAMINERS AMENDMENT MAILED
Mar 15, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 15, 2004MAILPAPER RECEIVED
Mar 1, 2004CNCFCONTINUATION OF FINAL REFUSAL MAILED
Nov 17, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 17, 2003MAILPAPER RECEIVED
Nov 12, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 8, 2003CFITCASE FILE IN TICRS
Oct 10, 2003MAILPAPER RECEIVED
Oct 7, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 28, 2003CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 23, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 23, 2003MAILPAPER RECEIVED
May 16, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 16, 2003MAILPAPER RECEIVED
Dec 10, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 18, 2002DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance